|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
08622 HUAKANG BIOMED
Nominal 
0.000 (0.000%) Profitability Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| ROAA (%) | -8.779% | -4.608% | -6.039% | -15.358% | -0.350% |
| ROAE (%) | -10.753% | -5.384% | -7.059% | -17.544% | -0.401% |
| Return on Capital Employed (%) | -11.073% | -5.431% | -7.223% | -18.329% | -0.397% |
Margin Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Gross Profit Margin (%) | 65.342% | 66.775% | 62.985% | 67.001% | 70.241% |
| EBITDA Margin (%) | -11.994% | -0.872% | -3.946% | -37.552% | 13.027% |
| Pre-tax Profit Margin (%) | -23.476% | -11.871% | -14.939% | -51.769% | 2.583% |
| Net Profit Margin (%) | -23.476% | -12.140% | -16.152% | -52.929% | -1.115% |
Liquidity Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Current Ratio (X) | 4.080 X | 5.462 X | 6.213 X | 6.368 X | 8.802 X |
| Quick Ratio (X) | 3.821 X | 5.143 X | 5.726 X | 6.070 X | 8.427 X |
Leverage Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Total Liabilities / Total Assets(%) | 21.888% | 14.876% | 13.950% | 14.913% | 10.198% |
| Total Debt / Total Assets (%) | 3.503% | 0.706% | 2.511% | 3.634% | 2.048% |
| Net Debt / Total Assets (%) | -46.922% | -49.447% | -51.481% | -54.060% | -59.941% |
| Total Debt / Shareholders' Funds (%) | 4.485% | 0.830% | 2.918% | 4.271% | 2.281% |
| Long Term Debt / Shareholders' Funds (%) | 2.307% | 0.104% | 1.152% | 1.998% | 0.610% |
| Net Debt / Shareholders' Funds (%) | -60.070% | -58.089% | -59.827% | -63.535% | -66.748% |
| Net Cash / (Debt) ($) | 30.647M | 32.834M | 34.523M | 39.302M | 47.181M |
| Net Cash / (Debt) per share ($) | 0.073 | 0.079 | 0.086 | 0.098 | 0.118 |
| Total Debt / Capital Employed (%) | 4.382% | 0.828% | 2.882% | 4.165% | 2.255% |
| Interest Coverage Ratio (X) | N/A | N/A | N/A | N/A | 10.139 X |
Efficiency Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Inventory Turnover (Day) | 139.205 Day | 158.863 Day | 131.643 Day | 137.687 Day | 120.070 Day |
| Receivables Turnover (Day) | 141.923 Day | 135.949 Day | 132.033 Day | 162.686 Day | 148.939 Day |
| Payables Turnover (Day) | 10.870 Day | 11.139 Day | 15.116 Day | 20.579 Day | 14.022 Day |
| Remarks: | Real time quote last updated: 07/11/2024 07:44 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -1,779,000 |
| %Change | 22.268% |
| EPS / (LPS) | RMB -0.004 |
| NBV Per Share (¥) | RMB 0.113 |